(Q45868800)
Statements
Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®)--an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia A (English)
U Martinowitz
J Bjerre
B Brand
R Klamroth
M Misgav
M Morfini
E Santagostino
28 March 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference